Wound Infection Clinical Trial
Official title:
A Randomized Trial Comparing the Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds Requiring Hospitalization
We have designed this study to determine whether performing two, compared with ≥3 operations has an effect on key clinical outcomes after discharge from the hospital of an infected wound that requires admission. Each arm of this study represents the two commonly practiced standard of care treatment plans for patients presenting with infected wounds. It is currently unknown which SoC option provides the best patient outcome.
There is a lack of consensus about whether or not a patient with an infected wound requires
more than 2 surgical procedures. For patients admitted for an infected wound this study will
investigate whether 2, compared with ≥3, operative interventions results in better outcomes.
All patients admitted for an infected wound will be assessed for eligibility in the study. If
eligible, subjects will be randomized into Cohort A (2 operative visits) or Cohort B (≥3
operative visits). Subjects will then be followed during the hospitalization as well as 180
days post discharge.
A total of 250 subjects will be enrolled into this study. Two operations (n=125) will be
compared with ≥3 operations (n=125) during the hospitalization. We will compare the following
factors between the two treatment groups: length of hospital stay; readmission
post-discharge; quality of life; proportion of wounds closed or covered with a graft; culture
results; host factors; environmental factors post-hospital discharge; and, financial charges
related to admission and readmission. We expect full enrollment to take 3 years in duration.
Debridement of the wound will be performed in the customary manner per SOC in the operating
room. Prior to the start of the study, the surgeons performing the operations will be
required to view a video that demonstrates the standardized debridement technique that will
be utilized. The following is the standardized technique depicted in the video:
All wound surfaces will be painted with dye prior to debridement. Debridement involves the
use of a scalpel, scissors, curette, rongeur, or hydro-surgery. A 2-3 millimeter skin edge
around the perimeter of the wound will also be resected. All infected/nonviable tissue will
be removed and all tissues with dye will be surgically removed. This includes decompression
of any purulent material and excision of any indurated tissue (until tissue pliability is
established). Nonviable tissue includes necrotic and fibrous tissue. Debridement will be
performed until the there is bleeding on the wound base and perimeter.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02905955 -
Vacuumtherapy After Venous Hybrid Procedures
|
Phase 4 | |
Not yet recruiting |
NCT02868372 -
Swabbing of Subcutaneous Tissues of Cesarean Section Wounds With Povidone Iodine
|
N/A | |
Completed |
NCT02744144 -
Wound Bacterial Microbiota and Their Antibiotic Resistance
|
N/A | |
Active, not recruiting |
NCT01939145 -
Comparing Outcomes for Prontosan Versus Normal Saline for Negative Pressure Wound Therapy With Instillation
|
Phase 4 | |
Completed |
NCT01141335 -
Polypropylene Mesh Versus Polytetrafluoroethylene (PTFE) Mesh in Inguinal Hernia Repair
|
Phase 4 | |
Completed |
NCT00998907 -
PDS*Plus and Wound Infections After Laparotomy
|
N/A | |
Completed |
NCT00576745 -
A Comparison Of The 3M TM S Surgical Skin Closure System To The Standard Vicryl Suture Closure of Sternotomy Incisions During Cardiac Surgery
|
Phase 1 | |
Terminated |
NCT00654641 -
Prevention of Wound Complications After Cesarean Delivery in Obese Women Utilizing Negative Pressure Wound Therapy
|
N/A | |
Completed |
NCT00402727 -
Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection
|
Phase 3 | |
Recruiting |
NCT00150852 -
Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.
|
Phase 2 | |
Not yet recruiting |
NCT03872544 -
Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
|
||
Recruiting |
NCT04596124 -
Effectiveness and Tolerability of Fitostimoline Plus Cream and Gauze vs Connettivina Bio Plus Cream and Gauze
|
N/A | |
Active, not recruiting |
NCT04584957 -
Prophylactic Negative Pressure Wound Therapy (VAC) in Gynecologic Oncology (G.O.)
|
N/A | |
Recruiting |
NCT03960970 -
Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries
|
Phase 2 | |
Enrolling by invitation |
NCT03880188 -
Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
|
||
Completed |
NCT02018094 -
The Amputation Surgical Site Infection Trial (ASSIT)
|
Phase 4 | |
Terminated |
NCT03269968 -
Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery
|
N/A | |
Enrolling by invitation |
NCT02945761 -
High Concentration of Sugar Solution Irrigation Promotes the Healing of Infected Wound
|
N/A | |
Not yet recruiting |
NCT02882360 -
Kerlix for Pregnant Women With Elevated BMI to Prevent Wound Infection by 6 Weeks Post Partum
|
Phase 4 | |
Enrolling by invitation |
NCT01977989 -
Vancomycin in Spine Surgery
|
Phase 4 |